A. C. Webster, E. V. Nagler, R. L. Morton, and P. Masson, Chronic Kidney Disease. The Lancet, vol.389, pp.1238-52, 2017.

M. Tonelli, P. Muntner, A. Lloyd, B. J. Manns, S. Klarenbach et al., Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. The Lancet, vol.380, pp.807-821, 2012.

H. C. Gerstein, J. F. Mann, Q. Yi, B. Zinman, S. F. Dinneen et al., Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals, JAMA, vol.286, issue.4, pp.421-427, 2001.

H. L. Hillege, V. Fidler, G. Diercks, W. H. Van-gilst, D. De-zeeuw et al., Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population, Circulation, vol.106, issue.14, pp.1777-82, 2002.

N. Jourde-chiche, F. Fakhouri, L. Dou, J. Bellien, S. Burtey et al., Endothelium structure and function in kidney health and disease, Nat Rev Nephrol, vol.15, issue.2, pp.87-108, 2019.
URL : https://hal.archives-ouvertes.fr/inserm-02160201

L. T. Roumenina, J. Rayes, M. Frimat, and V. Fremeaux-bacchi, Endothelial cells: source, barrier, and target of defensive mediators, Immunol Rev, vol.274, issue.1, pp.307-336, 2016.

F. Fakhouri, J. Zuber, V. Frémeaux-bacchi, and C. Loirat, Haemolytic uraemic syndrome, Lancet Lond Engl, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02155934

, Aug, vol.12, pp.681-96, 10095.

H. Cheng and R. C. Harris, Renal endothelial dysfunction in diabetic nephropathy, Cardiovasc Hematol Disord Drug Targets, vol.14, issue.1, pp.22-33, 2014.

C. Stehouwer, R. Henry, J. M. Dekker, G. Nijpels, R. J. Heine et al., Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction--the Hoorn Study, Kidney Int Suppl, issue.92, pp.42-44, 2004.

J. M. Lehmann, G. Riethmüller, and J. P. Johnson, MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily, Proc Natl Acad Sci, vol.86, issue.24, pp.9891-9896, 1989.

F. George, P. Poncelet, J. C. Laurent, O. Massot, D. Arnoux et al., Cytofluorometric detection of human endothelial cells in whole blood using S-Endo 1 monoclonal antibody, J Immunol Methods, vol.139, issue.1, pp.65-75, 1991.

N. Bardin, F. Anfosso, J. M. Massé, E. Cramer, F. Sabatier et al., Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion, Blood, vol.98, issue.13, pp.3677-84, 2001.

X. Yan, Y. Lin, D. Yang, Y. Shen, M. Yuan et al., A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth, Blood, vol.102, issue.1, pp.184-91, 2003.

B. Chan, S. Sinha, D. Cho, R. Ramchandran, and V. P. Sukhatme, Critical roles of CD146 in zebrafish vascular development, Dev Dyn Off Publ Am Assoc Anat, vol.232, issue.1, pp.232-276, 2005.

A. Kebir, K. Harhouri, B. Guillet, J. W. Liu, A. Foucault-bertaud et al., CD146 short isoform increases the proangiogenic potential of endothelial progenitor cells in vitro and in vivo, Circ Res, vol.107, issue.1, pp.66-75, 2009.

K. Harhouri, A. Kebir, B. Guillet, A. Foucault-bertaud, S. Voytenko et al., Soluble CD146 displays angiogenic properties and promotes neovascularization in experimental hind-limb ischemia, Blood, vol.115, issue.18, pp.3843-51, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01827654

W. F. Pickl, O. Majdic, G. F. Fischer, P. Petzelbauer, I. Faé et al., MUC18/MCAM (CD146), an activation antigen of human T lymphocytes, J Immunol Baltim Md, vol.158, issue.5, pp.2107-2122, 1950.

N. Bardin, M. Blot-chabaud, N. Despoix, A. Kebir, K. Harhouri et al., CD146 and its Soluble Form Regulate Monocyte Transendothelial Migration, Arterioscler Thromb Vasc Biol, vol.29, issue.5, pp.746-53, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00428932

C. Sers, K. Kirsch, U. Rothbächer, G. Riethmüller, and J. P. Johnson, Genomic organization of the melanomaassociated glycoprotein MUC18: implications for the evolution of the immunoglobulin domains, Proc Natl Acad Sci, vol.90, issue.18, pp.8514-8522, 1993.

S. Xie, M. Luca, S. Huang, M. Gutman, R. Reich et al., Expression of MCAM/MUC18 by Human Melanoma Cells Leads to Increased Tumor Growth and Metastasis, Cancer Res, vol.57, issue.11, pp.2295-303, 1997.

E. Taira, T. Nagino, H. Taniura, N. Takaha, C. H. Kim et al., Expression and functional analysis of a novel isoform of gicerin, an immunoglobulin superfamily cell adhesion molecule, J Biol Chem, vol.270, issue.48, pp.28681-28688, 1995.

N. Bardin, V. Francès, V. Combes, J. Sampol, and F. Dignat-george, CD146: biosynthesis and production of a soluble form in human cultured endothelial cells, FEBS Lett, vol.421, issue.1, pp.12-16, 1998.

N. Bardin, V. Moal, F. Anfosso, L. Daniel, P. Brunet et al., Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alteration, Thromb Haemost, p.2017, 2003.

,

J. Stalin, K. Harhouri, L. Hubert, P. Garrigue, M. Nollet et al., Soluble CD146 boosts therapeutic effect of endothelial progenitors through proteolytic processing of short CD146 isoform, Cardiovasc Res, vol.111, issue.3, pp.240-51, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01456844

N. Bardin, D. Reumaux, K. Geboes, J. F. Colombel, M. Blot-chabaud et al., Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease, Inflamm Bowel Dis, vol.12, issue.1, pp.16-21, 2006.

D. Reumaux, N. Bardin, J. Colombel, F. Dignat-george, P. Duthilleul et al., Restoration of soluble CD146 in patients with Crohn's disease treated with the TNF-alpha antagonist infliximab, Inflamm Bowel Dis, vol.13, issue.10, pp.1315-1322, 2007.

E. Nomikou, A. Alexopoulou, L. Vasilieva, D. Agiasotelli, E. Pavlou et al., Soluble CD146, a novel endothelial marker, is related to the severity of liver disease, Scand J Gastroenterol, vol.50, issue.5, pp.577-83, 2015.

D. Figarella-branger, N. Schleinitz, B. Boutière-albanèse, L. Camoin, N. Bardin et al., Plateletendothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies, J Rheumatol, vol.33, issue.8, pp.1623-1653, 2006.

E. Pasquier, N. Bardin, D. Saint-martin, L. , L. Martelot et al., The first assessment of soluble CD146 in women with unexplained pregnancy loss. A new insight? Thromb Haemost, vol.94, pp.1280-1284, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00722043

M. Neidhart, R. Wehrli, P. Brühlmann, B. A. Michel, R. E. Gay et al., Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis, Arthritis Rheum, vol.42, issue.4, pp.622-652, 1999.

T. Ito, N. Tamura, S. Okuda, K. Tada, M. Matsushita et al., Elevated serum levels of soluble CD146 in patients with systemic sclerosis, Clin Rheumatol, vol.36, issue.1, pp.119-143, 2017.

L. Daniel, N. Bardin, V. Moal, F. Dignat-george, Y. Berland et al., Tubular CD146 Expression in Nephropathies Is Related to Chronic Renal Failure, Nephron Exp Nephrol, vol.99, issue.4, pp.105-116, 2005.

F. Wang, T. Xing, N. Wang, and L. Liu, Clinical significance of plasma CD146 and P-selectin in patients with type 2 diabetic nephropathy, Cytokine, vol.57, issue.1, pp.127-136, 2012.

Y. Fan, Y. Fei, L. Zheng, J. Wang, X. W. Wen et al., Expression of Endothelial Cell Injury Marker Cd146 Correlates with Disease Severity and Predicts the Renal Outcomes in Patients with Diabetic Nephropathy, Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol, vol.48, issue.1, pp.63-74, 2018.

J. Ma?yszko, J. S. Ma?yszko, and M. My?liwiec, Is there a link between CD146, a novel adhesion molecule and other markers of endothelial dysfunction in nephrotic syndrome and continuous ambulatory peritoneal dialysis?, Thromb Res, vol.115, issue.1-2, pp.19-24, 2005.

T. Saito, O. Saito, T. Kawano, H. Tamemoto, E. Kusano et al., Elevation of serum adiponectin and CD146 levels in diabetic nephropathy, Diabetes Res Clin Pract, vol.78, issue.1, pp.85-92, 2007.

M. Bonomini, M. Reale, P. Santarelli, S. Stuard, N. Settefrati et al., Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients, Nephron, vol.79, issue.4, pp.399-407, 1998.

R. Vanholder,

, Nephrologie, vol.24, issue.7, pp.373-379, 2003.

H. W. Schnaper, The Tubulointerstitial Pathophysiology of Progressive Kidney Disease, vol.24, pp.107-123, 2017.

J. Liu, Q. Wei, C. Guo, G. Dong, Y. Liu et al., HIF, and Associated Signaling Networks in Chronic Kidney Disease, Int J Mol Sci, vol.18, issue.5, p.950, 2017.

J. Ma?yszko, J. S. Ma?yszko, S. Brzosko, S. Wo?czynski, and M. My?liwiec, Markers of endothelial cell activation/injury: CD146 and thrombomodulin are related to adiponectin in kidney allograft recipients, Am J Nephrol, vol.25, issue.3, pp.203-213, 2005.

Y. Qian, Y. Luo, H. Duan, L. Feng, Q. Bi et al., Adhesion molecule CD146 and its soluble form correlate well with carotid atherosclerosis and plaque instability, CNS Neurosci Ther, vol.20, issue.5, pp.438-483, 2014.